The FDA's Current Position on Peptides Explained Holt Law FDA to weigh easing limits on unproven peptides promoted by RFK Jr. FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law In 2023, the FDA deemed 19 peptide drugs too unsafe to be dispensed by compounding pharmacies, which mix components of approved drugs to create bespoke medication for people who have trouble taking Indictment of Osteopathic Physician Signals Shift in Peptide Enforcement Stevens & Lee